Skip to content
OpenCapital
Get started

Progyny PGNY Pharmacy benefits services revenue — Revenue

Other product segments

Fertility benefits services revenue
$209.43M+1.5%

Similar metrics at other companies

HWK
HWKNPharmaceutical — Revenue
$8.32M+15.1%
Weis Markets logo
WMKPharmacy — Revenue
$165.04M+11.4%
Aurinia Pharmaceuticals logo
AUPHService Revenue — Revenue
$4.1M+64.0%
Kiniksa Pharmaceuticals International, plc logo
KNSAPharmaceutical — Revenue
$214.27M+55.5%
Cigna logo
CIService — Revenue
$4.44B+14.1%
Veracyte logo
VCYTBiopharmaceutical revenue — Total Revenue
$301K-86.9%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
Enterprise value$1.98B-29.6%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's pharmacy benefits services revenue — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's pharmacy benefits services revenue — revenue?
Progyny (PGNY) reported pharmacy benefits services revenue — revenue of $119.07M in Q1 2026.
How has Progyny's pharmacy benefits services revenue — revenue changed year-over-year?
Progyny's pharmacy benefits services revenue — revenue increased by 1.2% year-over-year, from $117.63M to $119.07M.
What is the long-term trend for Progyny's pharmacy benefits services revenue — revenue?
Over 4 years (2021 to 2025), Progyny's pharmacy benefits services revenue — revenue has grown at a 33.3% compound annual growth rate (CAGR), from $145.01M to $457.73M.
What does pharmacy benefits services revenue — revenue mean?
This metric represents the total revenue generated from the provision of pharmacy benefit management services, specifically related to fertility-related medications and pharmaceutical support. It reflects the company's ability to capture value through the distribution and management of specialty drugs required for fertility treatments. This revenue stream is a critical component of the integrated benefits model, indicating the scale and adoption of the company's pharmaceutical solutions among employer clients.